Clinical experience with combination chemo-/immunotherapy using trabectedin and nivolumab for advanced soft tissue sarcoma.

e23568Background: Immune checkpoint inhibitors revive pre-existing immune responses that are suppressed in cancer. To restore tumor surveillance that is lost in cancer patients, a tumoricidal agent...